Sign in to fuzzto save your conversations, follow your research and come back anytime.
Curis Lifesciences
SectorHealthcare
| Metric (₹ crore) | Q1 FY25 |
|---|---|
| Sales | 9.12 |
| Expenses | 6.39 |
| EBITDA | 2.73 |
| Depreciation | 0.17 |
| EBIT | 2.56 |
| Interest | 0.25 |
| Profit Before Tax | 2.31 |
| Net Profit | 1.2 |
| EPS | 24 |
| Metric (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating Cash Flow | 4.95 | 3.35 | 0.28 | -2.03 | -16.42 |
| Investing Cash Flow | -0.37 | -0.55 | -0.06 | -0.02 | -1.59 |
| Financing Cash Flow | -4.58 | -2.76 | 0.05 | 1.94 | 20.87 |
| Net Cash Flow | -0 | 0.04 | 0.27 | -0.11 | 2.86 |
| Metric (₹ crore) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity / Shareholders' Funds | -0.9 | 0.32 | 5.68 | 16.52 | 47.36 |
| Total Liabilities | 28.3 | 29.35 | 28.14 | 26.08 | 34.16 |
| Total Assets | 27.4 | 29.67 | 33.82 | 42.6 | 81.52 |